12:00 AM
Jan 23, 2012
 |  BC Week In Review  |  Clinical News  |  Clinical Status

I-131-CLR1404: Phase Ib started

Novelos began an open-label, dose-escalation, U.S. Phase Ib trial to evaluate IV I-131-CLR1404 (HOT) in about 24 patients.


Read the full 77 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >